HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.

NCT05154851 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Congenital Muscular Dystrophy Due to Lamin A/C Mutation

Interventions

BIOLOGICAL: HB-adMSCs

Sponsor

Hope Biosciences Research Foundation